cell therapy
Astellas teams up with UK biotech Mogrify on hearing loss project
Phil Taylor
Astellas, cell therapy, hearing loss, Mogrify, otology, partnering, Regenerative medicine
0 Comment
Market Access/ News/ News/ News/ Oncology
Kymriah is first CAR-T cleared for follicular lymphoma in EU
Phil Taylor
CAR-T therapies, cell therapy, Gilead Sciences, immuno-oncology, Kymriah, Novartis, Oncology, regulatory approval, Yescarta
0 Comment
News/ News/ News/ Oncology/ R&D
Nkarta leaps on early CAR-NK data in blood cancers
Phil Taylor
acute myeloid leukaemia, car-nk, cell therapy, Haematology, immuno-oncology, lymphoma, Nkarta, Oncology
0 Comment
3rd Gamma Delta T Therapies Summit
Jessica Durston
cell therapy, gamma delta, natural killer cells, pharma, R&D
0 Comment
The Only Industry-Specific Event on γδT Therapies
Bayer backs KRAS TCR player Affini-T in $175m financing
Phil Taylor
Affini-T, cell therapy, immuno-oncology, KRAS, Oncology, p53, TCR
0 Comment
BMS cuts $3.15bn deal with Century for cancer cell therapies
Phil Taylor
acute myeloid leukaemia, Bristol-Myers Squibb, cell therapy, Century Therapeutics, Haematology, immuno-oncology, multiple myeloma, Oncology
0 Comment
Milestone as EMA starts review of Atara’s ‘off-the-shelf’ cell therapy
Phil Taylor
allogeneic, Atara, cell therapy, immuno-oncology, Oncology, Pierre Fabre, tabelecleucel
0 Comment
Blackstone revs up Autolus’ CAR with $250m fuel injection
Phil Taylor
acute lymphoblastic leukaemia, Autolus, Blackstone, CAR-T therapies, cell therapy, financing, immuno-oncology, Oncology
0 Comment